Strengthening Biologics Manufacturing and Supply Chain Resilience Through Fast and Robust Particle Identification

Visible and subvisible particles are a critical risk in biologics manufacturing with the potential to delay production and impact patient access and safety. This white paper shows how fast and robust particle identification enables rapid root cause analysis and confident decision-making. Through practical case studies, it highlights how advanced analytics and expert interpretation help protect product quality, reduce delays, and strengthen supply chain resilience.